Market Overview

Global Topical Pain Relief Market Outlook to 2025 by Therapeutic Class, Type, Formulation and Distribution Channel -


The "Topical
Pain Relief Market by Therapeutic Class, Type, Formulation and
Distribution Channel - Global Opportunity Analysis and Industry
Forecast, 2018-2025"
report has been added to's

The global topical pain relief market was valued at $7,481 million in
2017, and is projected to reach $13,276 million in 2025, registering a
CAGR of 7.4% from 2017 to 2025.

The factors that drive the growth of the topical pain relief market
include increase in prevalence of arthritis, diabetic neuropathy, and
other bone disorders across the globe, rise in geriatric population,
fewer side effects caused by topical pain relief as compared to oral
medications, and high adoption of topical pain relief products by

However, topical pain relief medications can cause irritation, and these
products are usually characterized by an unpleasant odor which impedes
the market growth. Conversely, the development of an online platform for
topical therapeutics and the untapped market potential in emerging
economies are expected to provide lucrative growth opportunities for the

The non-opioids segment accounted for the largest share in 2017 owing to
high usage in treatment of pain and lesser side effects as compared to

By type, the over-the counter pain relief segment dominated the global
topical pain relief market in terms of revenue in 2017 and the trend is
projected to continue throughout the forecast period.

The utilization rate of cream pain relief products is high owing to high
availability of these products with high success rate and lesser side
effects. However, the patch pain relief products segment is expected to
grow at a CAGR of 9% during the forecast period.

Companies Profiled

  • AdvaCare Pharma
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Nestle S.A.
  • Novartis AG
  • Pfizer Inc.
  • Reckitt Benckiser Group Plc
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Topical BioMedics Inc.

For more information about this report visit

View Comments and Join the Discussion!